Brief: Paradigm Biopharmaceuticals Confirms Submission To US FDA To Progress Phase 3 OA Program
19/04/2024 08:18
April 19 (Reuters) - Paradigm Biopharmaceuticals Ltd
PAR.AX :
* CONFIRMS SUBMISSION TO US FDA TO PROGRESS PHASE 3 OA
PROGRAM
Further company coverage: PAR.AX
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Paradigm Biopharmaceuticals
See all newsBrief: Paradigm Biopharmaceuticals Says Board Initiates Voluntary Administration
Brief: Paradigm Biopharmaceuticals Seeks Trading Halt
Australia's Paradigm Biopharmaceuticals slips on discounted placement
Brief: Paradigm Biopharmaceuticals Says Co Completes A$14 Mln Placement
Brief: Paradigm Biopharmaceuticals Requests Trading Halt